Associations of gut microbiome profiles with efficacy and toxicity in CD19-targeted chimeric antigen receptor (CAR) T cell treatment

被引：0
|
作者：
Schubert, M. -L [1 ]
Blumenberg, V. [2 ]
Zamir, E. [3 ]
Schmidt, S. [3 ]
Rohrbach, R. [3 ]
Waldhoff, P. [1 ]
Bozic, D. [1 ]
von Bergwelt, M. [2 ]
Mueller-Tidow, C. [1 ]
Dreger, P. [1 ]
Poeck, H. [4 ]
Schmitt, M. [1 ]
Subklewe, M. [2 ]
Stein-Thoeringer, C. [1 ,3 ]
机构：
[1] Univ Klinikum Heidelberg, Heidelberg, Germany
[2] Klinikum Ludwig Maximilians Univ LMU Munchen, Munich, Germany
[3] Deutsch Krebsforschungszentrum, Heidelberg, Germany
[4] Univ Klinikum Regensburg, Regensburg, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2021年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V372
引用
收藏
页码：43 / 43
页数：1
相关论文
共 50 条
  • [41] Outcomes of patients with primary central nervous system lymphoma following CD19-targeted chimeric antigen receptor T-cell therapy
    Mercadal, Santiago
    Ahn, Kwang Woo
    Allbee-Johnson, Mariam
    Ganguly, Siddhartha
    Geethakumari, Praveen Ramakrishnan
    Hong, Sanghee
    Malone, Adriana
    Murthy, Hemant
    Pawarode, Attaphol
    Sica, R. Alejandro
    Solh, Melhem
    Ustun, Celalettin
    Shadman, Mazyar
    Sauter, Craig S.
    Hamadani, Mehdi
    Herrera, Alex F.
    Lee, Catherine J.
    HAEMATOLOGICA, 2025, 110 (01) : 218 - 221
  • [42] CD19-TARGETED CHIMERIC ANTIGEN RECEPTOR (CAR)-MODIFIED T (CTL019) CELLS IN PEDIATRIC ALL: IMMUNE ACTIVATION SYNDROMES AND DURABLE RESPONSE
    Barrett, David
    Kalos, Michael
    Teachey, David
    Levine, Bruce
    Rheingold, Susan
    Aplenc, Richard
    Porter, David
    June, Carl
    Grupp, Stephan
    PEDIATRIC BLOOD & CANCER, 2013, 60 : S1 - S1
  • [43] CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia (vol 125, pg 4017, 2015)
    Maude, S. L.
    Teachey, D. T.
    Porter, D. L.
    Grupp, S. A.
    BLOOD, 2016, 128 (10) : 1441 - 1441
  • [44] T-CELL LARGE GRANULAR LYMPHOCYTE POPULATION INVOLVING CHIMERIC ANTIGEN RECEPTOR-MODIFIED T (CAR T) CELLS IN PATIENTS WITH CYTOPENIA AFTER CD19-TARGETED CAR T-CELL THERAPY: CASE SERIES
    Albittar, Aya
    Torabi, Alireza
    Liang, Emily
    Portuguese, Andrew
    Huang, Jennifer
    Yeung, Cecilia
    Kimble, Erik
    Kirchmeier, Delaney
    Torkelson, Aiko
    Chutnik, Abigail
    Cassaday, Ryan
    Chapuis, Aude
    Kiem, Hans-Peter
    Milano, Filippo
    Otegbeye, Folashade
    Shadman, Mazyar
    Till, Brian
    Maloney, David
    Turtle, Cameron
    Gauthier, Jordan
    Hirayama, Alexandre
    BONE MARROW TRANSPLANTATION, 2024, 59 : 230 - 231
  • [45] Humanized CD19-Targeted Chimeric Antigen Receptor (CAR) T Cells in CAR-Naive and CAR-Exposed Children and Young Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia
    Myers, Regina M.
    Li, Yimei
    Leahy, Allison Barz
    Barrett, David M.
    Teachey, David T.
    Callahan, Colleen
    Fasano, Christina C.
    Rheingold, Susan R.
    DiNofia, Amanda
    Wray, Lisa
    Aplenc, Richard
    Baniewicz, Diane
    Liu, Hongyan
    Shaw, Pamela A.
    Pequignot, Edward
    Getz, Kelly D.
    Brogdon, Jennifer L.
    Fesnak, Andrew D.
    Siegel, Donald L.
    Davis, Megan M.
    Bartoszek, Chelsie
    Lacey, Simon F.
    Hexner, Elizabeth O.
    Chew, Anne
    Wertheim, Gerald B.
    Levine, Bruce L.
    June, Carl H.
    Grupp, Stephan A.
    Maude, Shannon L.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (27) : 3044 - +
  • [46] Are we ready for CD19-targeted CAR T-cell therapies in MS?
    Giovannoni, Gavin
    Hawkes, Christopher H.
    Lechner-Scott, Jeannette
    Levy, Michael
    Yeh, E. Ann
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 70
  • [47] Chimeric Antigen Receptor (CAR) T Cells Targeting the CD19 Antigen for the Treatment of Pediatric Relapsed B Cell ALL
    Curran, Kevin J.
    Riviere, Isabelle
    Kobos, Rachel
    Kernan, Nancy A.
    Boulad, Farid
    Prockop, Susan E.
    Scaradavou, Andromachi
    Renaud, Thomas M.
    Shukla, Neerav
    Steinherz, Peter G.
    Park, Jae H.
    Sauter, Craig S.
    O'Reilly, Richard J.
    Sadelain, Michel
    Brentjens, Renier J.
    BLOOD, 2014, 124 (21)
  • [48] Characterizing Environmental Adaption and Virulence of Gut Microbiome Enterococcus Spp. from Patients Receiving CD19-Targeted CAR-T Cell Therapy
    Deschl, Niklas
    Blumenberg, Viktoria
    Schubert, Maria-Luisa
    Schmitt, Anita
    Schmitt, Michael
    Subklewe, Marion
    Stein-Thoeringer, Christoph
    BLOOD, 2024, 144 : 3415 - 3416
  • [49] Late adverse events in patients with aggressive B-cell lymphoma after CD19-targeted chimeric antigen receptor T-cell therapy
    Camacho Arteaga, Lina
    Leguizamo Martinez, Lina Maria
    Filippi Arriaga, Francesca
    Iacoboni Garcia-Calvo, Gloria
    Alonso Martinez, Carla
    Vidal Guitart, Xavier
    Lopez Corral, Lucia
    Perez Lopez, Estefania
    Kwon, Mi
    Bailen Almorox, Rebeca
    Hernani Morales, Rafael
    Guerreiro, Manuel
    Maiquez Asuero, Maria Pilar
    Barba Sunol, Pere
    Agusti Escasany, Antonia
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2022, 130 : 22 - 22
  • [50] Combination of Anti-CD123 and Anti-CD19 Chimeric Antigen Receptor T Cells for the Treatment and Prevention of Antigen-Loss Relapses Occurring after CD19-Targeted Immunotherapies
    Ruella, Marco
    Barrett, David M.
    Kenderian, Saad S.
    Shestova, Olga
    Hofmann, Ted J.
    Scholler, John
    Lacey, Simon F.
    Melenhorst, J. Joseph
    Nazimuddin, Farzana
    Perazzelli, Jessica
    Christian, David A.
    Hunter, Christopher A.
    Porter, David L.
    June, Carl H.
    Grupp, Stephan A.
    Gill, Saar I.
    BLOOD, 2015, 126 (23)
12345